Twitter | Pretraživanje | |
Atriva Therapeutics
Learn more about ’s host-targeting therapy candidate against , hanta and further severe respiratory viral infections at the company presentation of our CEO, Dr. Lichtenberger, today at . Join us at 11:30, Franciscan D.
Reply Retweet Označi sa "sviđa mi se" More
Sherwood Yao 13. sij
Odgovor korisniku/ci @AtrivaTx
Can we meet Dr Litchenberger at JPM event at SF? my team () is working on flu inhibitor drug delivery. I'm the co-founder and here at the event.
Reply Retweet Označi sa "sviđa mi se"